First approval filing for Asahi Kasei's teriparatide acetate
This article was originally published in Scrip
Executive Summary
Asahi Kasei Pharma has made the first approval filing worldwide, in Japan, for its synthetic human parathyroid hormone (PTH) preparation teriparatide acetate (MN-10-T).